Table 1.
Characteristics (clinical and histopathological) | Number of patients, n (%) |
---|---|
Age | |
21-40 | 8 (26.6) |
41-60 | 17 (56.6) |
61 and above | 5 (16.6) |
Gender | |
Male | 24 (80) |
Female | 6 (20) |
Site of lesion | |
Buccal mucosa | 10 (33.3) |
Tongue | 7 (23.3) |
Alveolus | 7 (23.3) |
Retromolar trigone | 4 (13.3) |
Gingivobuccal sulcus | 1 (3.3) |
Floor of mouth | 1 (3.3) |
Clinical stage | |
Stage I | 4 (13.3) |
Stage II | 4 (13.3) |
Stage III | 8 (26.7) |
Stage IV | 14 (46.7) |
Degree of differentiation | |
Well differentiated | 28 (93.3) |
Moderately differentiated | 1 (3.3) |
Poorly differentiated | 1 (3.3) |
Pattern of invasion | |
Type 1 | 7 (23.3) |
Type 2 | 5 (16.7) |
Type 3 | 10 (33.3) |
Type 4 | 4 (13.3) |
Type 5 | 4 (13.3) |
Lymphocytic host response | |
Strong | 18 (60) |
Interim | 5 (16.6) |
Weak | 7 (23.3) |
Tumour budding | |
Score 0 | 2 (6.6) |
Score 1 | 3 (10) |
Score 2 | 25 (83.3) |
Depth of invasion | |
Score 1 | 1 (3.3) |
Score 2 | 29 (96.7) |
BD score | |
Score 0-low risk | 0 (0) |
Score 1- intermediate risk | 6 (20) |
Score 2- high risk | 24 (80) |
Treatment modalities | |
Surgery only | 13 (43.3) |
Surgery + RT | 10 (33.3) |
Surgery + RT + CT | 5 (16.7) |
Surgery + CT | 2 (6.7) |
Follow-up | |
Alive | 17 (56.7) |
Dead | 7 (23.3) |
Lost to follow up | 6 (20) |
CT: Chemotherapy, RT: Radiotherapy, BD: Budding and Depth of Invasion